|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01858 CHUNLI MEDICAL
Nominal 
8.450 +0.150 (+1.807%) | 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |
| Turnover | 1,208,524 | 0.576% | 1,201,604 | 1,108,140 | 937,686 | 855,327 |
| Cost of Sales | -- | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- | -- |
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (15,412) | -25.825% | (20,777) | (27,290) | (6,224) | (15,102) | |
| Profit / (Loss) on Disposal | 4 | -84.570% | 25 | 15 | (158) | (79) | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 305,906 | -9.194% | 336,880 | 367,379 | 329,847 | 273,001 | |
| Taxation | (28,088) | -3.679% | (29,161) | (45,018) | (46,473) | (36,239) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 6 | -- | 0 | 0 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 277,824 | -9.715% | 307,719 | 322,361 | 283,373 | 236,761 | |
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |
| Net Finance Costs / (Income) | (16,582) | -17.809% | (20,175) | (9,642) | (1,637) | (4,893) |
| Depreciation & Amortisation | 34,655 | 14.898% | 30,162 | 18,526 | 15,166 | 12,015 |
| Directors' Emoluments | 3,938 | 4.176% | 3,780 | 3,444 | 3,758 | 3,315 |
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| EPS (cts) | 72.000 | -10.000% | 80.000 | 93.000 | 82.000 | 68.000 |
| DPS (cts) | 36.200 | -- | 31.300 | 13.000 | 0.000 | 6.000 |
| Dividend Payout Ratio (%) | 50.278% | -- | 39.125% | 13.978% | -- | 8.824% |
| Cash flow per share ($) | 1.334 | -- | 0.107 | 0.476 | 0.754 | 0.669 |
| NBV per share ($) | 7.502 | -- | 7.077 | 6.425 | 3.122 | 2.332 |
| Remarks: | Real time quote last updated: 29/11/2024 13:10 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB 79,026,079 |
| %Change | -37.319% |
| EPS / (LPS) | RMB 0.210 |
| NBV Per Share (¥) | RMB 7.346 |